CORAL SPRINGS, FL -- (Marketwire) -- 06/20/12 -- FinancialNewsMedia.com "stocks to watch" for today: Ziyang Ceramics Corporation (OTCBB: ZYCI), Bank of America Corp. (NYSE: BAC), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX).
Potential Breakout Alert issued for ZYCI: Bullworthy, LLC Initiates Coverage on Ziyang Ceramics Corporation (OTCBB: ZYCI) With Detailed Research Report that includes a $9.25 Target Price per share.
Bullworthy, LLC, a digital investor and press relations firm focused on producing high-quality web content, is pleased to announce the company's analysts have initiated coverage on Ziyang Ceramics Corporation (OTCBB: ZYCI), a leading manufacturer of interior porcelain wall and floor tiling for residential and commercial applications in Zhucheng, China.
The 25-page detail report covers the history of earnings for the China-based tile manufacturer, the many aspects of its growing business and operations, and the global marketplace demand for high-quality, interior wall and floor tiling.
The report comes on the heels of Ziyang Ceramics reporting impressive 1Q 2012 earnings on May 16th, 2012, in which the company reported net revenues of $11.4 million, an increase of 52.5% from the first quarter of 2011. The company also reported net income of $3.2 million, or $.42 per share on 7.5 million shares outstanding, its fourth straight profitable quarter.
Bullworthy, LLC's 12-18 month price target using the Bullworthy Composite Valuation Model (BCVM) is $9.25 a share. The model is calculated using formulas that include price-to-earnings ratios, price-to-book ratios, and discounted cash flow with conservative variables, and smoothed for a final, average price target.
To Read the Entire FREE 25 Page Research Report, Go to http://zyci.bullworthy.com/
For more details and to read the entire press release issued for ZYCI that includes the full company disclosures please go to http://www.financialnewsmedia.com/stock-investing-business-investing-news/featured-news.php?id=159
Don't miss out on future alerts of this emerging company, sign up for our free News Alerts now at http://www.financialnewsmedia.com.
Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com.
Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup
Bank of America Corp. (NYSE: BAC) has recently overtaken JPMorgan as the top lender to the commodities industry during first five months of the year. According to data collected by Bloomberg total commodity loans for Bank of America were $14.71 billion compared to $14.41 billion from JPMorgan. Citigroup was ranked third with $13.68 billion in commodity loans.
In the past 52 weeks, Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) share prices have been bracketed by a low of US$1.23 and a high of US$9.55, and are now at US$9.38 (662% above that low price). There were 46.13 million stock shares traded, which was 2.2 times more than the average volume.
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, announced results from an ongoing phase IIb study of IDX184 in combination with pegylated interferon and ribavirin (PegIFN/RBV).
If you're a company interested in having FN Media Group assist you with creating a greater awareness for your next news release utilizing our multi-media and leading edge outreach solutions, contact us now at firstname.lastname@example.org
DISCLAIMER: FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For disseminating this release, FNMG expects to be compensated five thousand dollars for this and future news coverage of Ziyang Ceramics Corporation (OTCBB: ZYCI) by a non-affiliated third party. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.